Curoverse

Curoverse announced today that the open-source, multi-platform Arvados system is now available on Microsoft Azure. On Azure, Arvados provides capabilities for managing and processing genomic and health data at petabyte scale. “We saw clear demand for Microsoft Azure from major institutions collecting and analyzing genomic data,” said Adam Berrey chief executive officer at Curoverse. “Microsoft Azure offers powerful capabilities and broad institutional support for research and pharmaceutical organizations, so we are excited to collaborate with Microsoft to deliver Arvados on Azure.”

Read More »